V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20223084 | 20084617 | 1.82 | 73.7 | Disease modification (D) | 2016-10-21 | 2016-10-21 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100789632 |
| 20223087 | 20084618 | 1.6 | 63.5 | 03 | 2019-03-10 | 2019-03-17 | Enzalutamide | 2 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100037041 |
| 20223090 | 20084619 | null | null | Neo-adjuvant (N) | 2019-04-23 | 2019-04-24 | Capecitabine + Cisplatin + RT | 02 | Y | CETUXIMAB + OXALIPLATIN + MDG | 100636239 |
| 20223092 | 20084620 | 1.6 | 56.7 | Palliative (P) | 2018-10-11 | 2018-10-11 | ECF | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100767851 |
| 20223099 | 20084621 | 1.76 | 68 | null | 2019-01-13 | 2019-01-14 | Cisplatin | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101025838 |
| 20223101 | 20084622 | 1.82 | 81.7 | Palliative (P) | 2018-03-11 | 2018-03-30 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100180582 |
| 20223102 | 20084623 | 1.81 | 66.2 | Curative (C) | 2019-11-03 | 2019-11-04 | Capecitabine + Cisplatin + RT | N | Y | CAPECITABINE + CISPLATIN + RT | 101026356 |
| 20223103 | 20084624 | 1.68 | 80.3 | Curative (C) | 2019-01-19 | 2019-01-19 | Enzalutamide | 02 | N | CARBOPLATIN | 100366126 |
| 20223108 | 20084625 | 1.75 | 52.6 | Neo-adjuvant (N) | 2016-05-01 | 2016-05-06 | CARBOPLATIN + PACLITAXEL + RT | 02 | Y | CARBOPLATIN + PACLITAXEL + RT | 101779787 |
| 20223110 | 20084626 | 1.82 | 75.9 | null | 2017-06-12 | 2017-06-12 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101501843 |
| 20223123 | 20084627 | 1.73 | 57.3 | Neo-adjuvant (N) | 2017-02-08 | 2017-02-22 | Capecitabine + Cisplatin + RT | 02 | N | CISPLATIN | 101855763 |
| 20223125 | 20084628 | null | 81 | null | 2019-08-22 | 2019-08-22 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100588239 |
| 20223126 | 20084629 | 1.67 | 41.2 | Palliative (P) | 2016-04-16 | 2016-04-16 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100497533 |
| 20223131 | 20084630 | 1.74 | 96 | Curative (C) | null | 2019-07-24 | Mitomycin Intravesical | N | null | MITOMYCIN INTRAVESICULAR | 100114473 |
| 20223134 | 20084631 | 1.6 | 72 | Palliative (P) | 2019-06-09 | 2019-06-09 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 101012544 |
| 20223139 | 20084632 | 1.73 | 79.7 | Palliative (P) | 2019-07-28 | 2019-07-28 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | CETUXIMAB | 100731366 |
| 20223143 | 20084633 | 1.69 | 66.3 | Curative (C) | 2016-04-28 | 2016-06-03 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101363001 |
| 20223145 | 20084634 | 1.71 | 69 | Neo-adjuvant (N) | 2018-02-13 | 2018-03-02 | Enzalutamide | 2 | N | TRASTUZUMAB | 101302048 |
| 20223149 | 20084635 | 1.76 | 70.5 | Neo-adjuvant (N) | 2018-09-26 | 2018-10-05 | Enzalutamide | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101404989 |
| 20223156 | 20084636 | 1.6 | 95.5 | Curative (C) | 2019-05-08 | 2019-05-08 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100097706 |
| 20223166 | 20084637 | 1.69 | 58.8 | Curative (C) | 2018-07-22 | 2018-07-22 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100805678 |
| 20223167 | 20084638 | 1.7 | 96 | null | null | 2017-09-25 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100198310 |
| 20223172 | 20084639 | 1.56 | 74.8 | Palliative (P) | 2019-08-29 | 2019-09-03 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101659589 |
| 20223175 | 20084640 | 1.58 | 75 | Disease modification (D) | 2017-12-11 | 2017-12-11 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100708984 |
| 20223177 | 20084641 | 1.76 | 78.8 | null | 2019-08-21 | 2019-08-28 | Enzalutamide | N | null | TRASTUZUMAB | 100651064 |
| 20223184 | 20084642 | 1.76 | null | Neo-adjuvant (N) | 2018-01-06 | 2018-01-06 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100270823 |
| 20223185 | 20084643 | 0 | 0 | 03 | 2018-04-28 | 2018-04-29 | Enzalutamide | 99 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100866444 |
| 20223193 | 20084644 | 1.78 | 58 | null | 2019-08-06 | 2019-08-06 | Capecitabine + Cisplatin + RT | 02 | null | CARBOPLATIN | 101448378 |
| 20223198 | 20084645 | 1.62 | 91.9 | Palliative (P) | 2016-04-28 | 2016-05-08 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100334003 |
| 20223206 | 20084646 | 1.6 | 65.2 | Palliative (P) | 2019-11-08 | 2019-11-10 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101104363 |
| 20223209 | 20084647 | 1.59 | 134.3 | Palliative (P) | 2019-09-19 | 2019-09-20 | Cetuximab 14 day | null | N | CARBOPLATIN + GEMCITABINE | 101837514 |
| 20223215 | 20084648 | 1.63 | 59.8 | Curative (C) | 2016-12-10 | 2016-12-10 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 100222135 |
| 20223217 | 20084649 | 1.74 | 50.8 | null | 2014-06-10 | 2014-06-15 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | CETUXIMAB + OXALIPLATIN + MDG | 100721875 |
| 20223219 | 20084650 | 1.9 | 122 | Curative (C) | 2016-08-20 | 2016-09-09 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100390634 |
| 20223220 | 20084651 | 1.66 | 74.2 | Neo-adjuvant (N) | 2018-12-24 | 2018-12-24 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100333396 |
| 20223227 | 20084652 | 1.5 | 66.2 | Neo-adjuvant (N) | 2016-06-02 | 2016-06-06 | Enzalutamide | 02 | Y | ECF | 101217433 |
| 20223229 | 20084653 | 1.7 | 45.9 | Palliative (P) | 2017-08-03 | 2017-08-23 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100263099 |
| 20223233 | 20084654 | 1.54 | 64.6 | null | 2016-08-14 | 2016-08-22 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100859023 |
| 20223239 | 20084655 | null | 88 | null | 2018-12-22 | 2018-12-24 | Enzalutamide | 02 | null | CETUXIMAB | 101856635 |
| 20223241 | 20084656 | null | 71.5 | Curative (C) | 2019-11-11 | 2019-12-03 | LUTETIUM-177 | 02 | Y | LUTETIUM-177 | 100846768 |
| 20223257 | 20084657 | null | 65 | Palliative (P) | 2017-07-16 | 2017-07-23 | Enzalutamide | 2 | N | ENZALUTAMIDE | 100702190 |
| 20223258 | 20084658 | null | 64.4 | Palliative (P) | 2019-09-12 | 2019-09-30 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101484740 |
| 20223266 | 20084659 | 1.69 | null | Curative (C) | 2016-12-10 | 2017-01-05 | Enzalutamide | 02 | Y | ATEZOLIZUMAB + BEVACIZUMAB | 100084650 |
| 20223272 | 20084660 | 1.69 | 75.4 | Palliative (P) | 2017-08-10 | 2017-08-10 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100588758 |
| 20223275 | 20084661 | 1.79 | 8.5 | Palliative (P) | 2015-06-24 | 2015-07-02 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 100629730 |
| 20223281 | 20084662 | 0 | 91.5 | null | 2019-10-18 | 2019-11-05 | Enzalutamide | N | null | ATEZOLIZUMAB + BEVACIZUMAB | 101479474 |
| 20223284 | 20084663 | 1.68 | 60 | Neo-adjuvant (N) | 2018-01-17 | 2018-01-17 | Cetuximab 14 day | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101761779 |
| 20223292 | 20084664 | 1.7 | 95 | Neo-adjuvant (N) | 2019-07-20 | 2019-07-20 | Enzalutamide | 02 | N | CARBOPLATIN | 101445455 |
| 20223298 | 20084665 | 1.66 | 71.3 | Palliative (P) | 2017-05-07 | 2017-05-07 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101236494 |
| 20223299 | 20084666 | 1.73 | 68.4 | Palliative (P) | 2016-04-24 | 2016-04-24 | Enzalutamide | N | N | CISPLATIN | 100153327 |